Enforcement Report - Week of April 13, 2022
13 Apr 2022 //
FDA
Health Canada Recalls Sandoz`s Orphenadrine
27 Oct 2021 //
HEALTH CANADA
Muscle-relaxant OrfenAce 100 mg tablets recalled because of nitrosamine impurity
16 Apr 2021 //
HEALTHYCANADIANS